Companies: 10,795·Total market cap: $144.5T
Prothena Corporation plc

Prothena Corporation plc

PRTANASDAQHealthcare● Active
$8.56
$-0.23(-2.62%)
Market Cap$448143709
P/E Ratio
52W High$11.8
52W Low$4.76

Prothena Corporation plc (PRTA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · PRTA · as of Feb 27, 2026

Latest filing snapshot

100
-63-38.65%vs prior year

Prothena Corporation plc (PRTA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
100
Change (1Y)
-63
Growth % (1Y)
-38.65%
Revenue / Employee
$96.8K
Net Income / Employee
$-2.44M
Market Cap
$448M

PRTA Employee Count

2012 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-27100-63-38.65%
2025-02-27163-10-5.78%
2024-02-22173+46+36.22%
2023-02-28127+45+54.88%
2022-02-2582+16+24.24%
2021-02-2666+15+29.41%
2020-03-0351-8-13.56%
2019-03-1559-66-52.80%
2018-02-26125+29+30.21%
2017-02-2796+30+45.45%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Bicycle Therapeutics plc
BCYC
Bicycle Therapeutics plc
305
#2
4D Molecular Therapeutics, Inc.
FDMT
4D Molecular Therapeutics, Inc.
227
#3
KalVista Pharmaceuticals, Inc.
KALV
KalVista Pharmaceuticals, Inc.
150
#4
Gossamer Bio, Inc.
GOSS
Gossamer Bio, Inc.
144
#5
Neumora Therapeutics, Inc. Common Stock
NMRA
Neumora Therapeutics, Inc. Common Stock
110
#6
Prothena Corporation plc
PRTA
Prothena Corporation plcYOU
100
#7
Corvus Pharmaceuticals, Inc.
CRVS
Corvus Pharmaceuticals, Inc.
31
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · PRTA peer comparison

About PRTA employees

PRTA Employees · Headcount

Prothena Corporation plc (PRTA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Prothena Corporation plc had 100 full-time employees globally. Full-time employees only. Global consolidated headcount.

Prothena Corporation plc employs 100 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $96,840, reflecting the company's operational efficiency.

Prothena Corporation plc's workforce decreased by 63 (38.65%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Prothena Corporation plc's revenue per employee of $96,840 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

PRTA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Prothena Corporation plc had 100 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Prothena Corporation plc employee counthow many employees does Prothena Corporation plc havePRTA total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-27